3-Bromocinnamic acid

3-Bromocinnamic acid is a long-term treatment that inhibits the adenosine receptor, which is an important component of the central nervous system. It has been shown to have biological properties such as cell growth inhibition, depressant effect, and inhibitory effects on HIV replication. 3-Bromocinnamic acid also inhibits the action of sodium salts in vitro and in vivo, suggesting that this drug may be useful for the treatment of epilepsy. 3-Bromocinnamic acid can be used to study the mechanisms by which sirt1 inhibitors act as anticancer drugs. In addition, 3-bromocinnamic acid has been shown to have therapeutic potential for treating Alzheimer's disease and Parkinson's disease.